company background image
A153710 logo

Optipharm.CO.LTD KOSDAQ:A153710 Stock Report

Last Price

₩5.06k

Market Cap

₩74.2b

7D

-2.9%

1Y

-28.4%

Updated

01 Nov, 2024

Data

Company Financials

A153710 Stock Overview

Operates as a biomedical solution provider in South Korea.

A153710 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Optipharm.CO.,LTD Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Optipharm.CO.LTD
Historical stock prices
Current Share Price₩5,060.00
52 Week High₩7,870.00
52 Week Low₩4,950.00
Beta0.55
11 Month Change-5.60%
3 Month Change-17.72%
1 Year Change-28.43%
33 Year Change-49.25%
5 Year Change-46.68%
Change since IPO-56.75%

Recent News & Updates

Recent updates

Shareholder Returns

A153710KR BiotechsKR Market
7D-2.9%-2.5%-1.2%
1Y-28.4%40.2%4.8%

Return vs Industry: A153710 underperformed the KR Biotechs industry which returned 44.3% over the past year.

Return vs Market: A153710 underperformed the KR Market which returned 7.2% over the past year.

Price Volatility

Is A153710's price volatile compared to industry and market?
A153710 volatility
A153710 Average Weekly Movement2.8%
Biotechs Industry Average Movement9.6%
Market Average Movement6.7%
10% most volatile stocks in KR Market12.3%
10% least volatile stocks in KR Market3.6%

Stable Share Price: A153710 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A153710's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000n/an/awww.optipharm.co.kr

Optipharm CO.,LTD operates as a biomedical solution provider in South Korea. It also engages in animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, xenotransplantation, and other optipharm products, as well as veterinary drug for feed additives and laboratory animal Medipig business.

Optipharm.CO.,LTD Fundamentals Summary

How do Optipharm.CO.LTD's earnings and revenue compare to its market cap?
A153710 fundamental statistics
Market cap₩74.23b
Earnings (TTM)-₩2.45b
Revenue (TTM)₩18.56b

4.0x

P/S Ratio

-30.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A153710 income statement (TTM)
Revenue₩18.56b
Cost of Revenue₩14.17b
Gross Profit₩4.39b
Other Expenses₩6.84b
Earnings-₩2.45b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-167.21
Gross Margin23.64%
Net Profit Margin-13.22%
Debt/Equity Ratio46.0%

How did A153710 perform over the long term?

See historical performance and comparison